Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals
- 1 October 2002
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 44 (2), 169-174
- https://doi.org/10.1016/s0732-8893(02)00440-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Oral manifestations of HIV infection in 600 South African patients.Journal of Oral Pathology & Medicine, 2007
- Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.Diagnostic Microbiology and Infectious Disease, 1998
- International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY ProgramJournal of Clinical Microbiology, 1998
- Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosisAIDS, 1997
- The Value of Cellular Fatty Acid Analysis in the Identification of Oral YeastsSystematic and Applied Microbiology, 1996
- Emergence of azole drug resistance in Candida species from HIV-infected patients receivingprolonged fluconazole therapy for oral candidosisJournal of Antimicrobial Chemotherapy, 1995
- Epidemiology and Control of Fungal InfectionsClinical Infectious Diseases, 1994
- Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDSOral Surgery, Oral Medicine, Oral Pathology, 1994
- Evaluation of prognosis and survival of the HIV-infected patientOral Surgery, Oral Medicine, Oral Pathology, 1992
- The prevalence and intra-oral distribution of Candida albicans in manArchives of Oral Biology, 1980